Mark Identification

NURENEX

Serial Number

76476989

Filing Date

Dec 19, 2002

Registration Date

Sep 16, 2003

Trademark by

UNIFUND CORPORATION

Classification Information

Medicinal preparations in the form of powders, capsules, tablets, salves, ointments, oils, solutions, and drops all used as a neuro-degenerative inhibitor, neuro-endocrine modulator, and neuro-cerebral metabolism enhancer for the elimination of anxiety and hyperactivity, mitigation of panic symptomology, reduction of fatigue, improvement of self-confidence and self-esteem, elimination of the need for anti-depressants, cognitive enhancement including improved concentration, clarity, and mental focus, improvement of aerobic endurance and performance and weight-training capacity, improvement of blood circulation, reduction of blood pressure and hypertension, improvement of sexual performance and libido, reduction of hormonal disbalance in menopausal and post-menopausal women, improvement of visual and auditory acuity, improvement of physical agility and muscle flexibility, improvement of social interaction skills, promotion of relaxation response and mitigation of chronic sleep pattern disorders such as insomnia and other chronic sleep disorders, reduction of arthritic pain and swelling, enhancement of immune system functioning, improvement of the metabolism including relief from constipation; improvement of the skin tone; mitigation of 'jet lag'; and reduction in caffeine dependence, and the treatment of a broad spectrum of conditions and pathologies, including certain pre-existing medical as well as age-related and neuro-degenerative conditions and pathologies including nerve diseases, general anxiety disorder, depression, neurosis, neurasthenia, obsessive-compulsive disorder, chronic sleep disorder, chronic fatigue syndrome, digestive diseases, chronic constipation, hypertension, osteoarthritis pain and swelling, and human sexual desire disorder

Pharmaceuticals